{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:16:12Z","timestamp":1778822172300,"version":"3.51.4"},"reference-count":205,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020921","name":"Indo Soviet Friendship College of Pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.intimp.2026.116668","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:32:43Z","timestamp":1777361563000},"page":"116668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Raloxifene Beyond Osteoporosis: Unlocking Neurorestoration Through Remyelination, Inflammatory Regulation, and Neuroimmune Modulation in CNS Pathologies"],"prefix":"10.1016","volume":"181","author":[{"given":"Chandrayee","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidharth","family":"Mehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May","key":"10.1016\/j.intimp.2026.116668_bb0005","article-title":"Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance","volume":"99","author":"Gadhave","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"March","key":"10.1016\/j.intimp.2026.116668_bb0010","first-page":"1","article-title":"Neurodegenerative diseases \u2013 is metabolic deficiency the root cause?","volume":"14","author":"Muddapu","year":"2020","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0015","first-page":"406","article-title":"Dementia \u2013 a complete literature review on various mechanisms involves in pathogenesis and an intracerebroventricular streptozotocin induced Alzheimer\u2019s disease","author":"Mehan","year":"2012","journal-title":"Inflamm Dis - Immunopathol Clin Pharmacol Bases."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0020","doi-asserted-by":"crossref","first-page":"001","DOI":"10.17352\/ojpdt.000001","article-title":"Restoration of mitochondrial dysfunction in 6-hydroxydopamine induced Parkinson\u2019s disease: a complete review","volume":"1","author":"Mehan","year":"2017","journal-title":"Open Journal of Parkinson\u2019s Disease and Treatment"},{"issue":"November 2023","key":"10.1016\/j.intimp.2026.116668_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuroscience.2024.04.004","article-title":"Immune system dysregulation in the progression of multiple sclerosis: molecular insights and therapeutic implications","volume":"548","author":"Khan","year":"2024","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.intimp.2026.116668_bb0030","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1007\/s11064-021-03366-2","article-title":"Nrf2\/HO-1 signaling activator acetyl-11-keto-beta boswellic acid (AKBA)-mediated neuroprotection in methyl mercury-induced experimental model of ALS","volume":"46","author":"Minj","year":"2021","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0035","doi-asserted-by":"crossref","DOI":"10.4103\/1673-5374.200812","article-title":"Adenyl cyclase activator forskolin protects against Huntington \u2019 s disease-like neurodegenerative disorders","volume":"12","author":"Mehan","year":"2017","journal-title":"Neural Regen. Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031851","article-title":"A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics","volume":"23","author":"Lamptey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.116668_bb0045","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1007\/s00210-023-02939-y","article-title":"Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders","volume":"397","author":"Giri","year":"2024","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"February","key":"10.1016\/j.intimp.2026.116668_bb0050","article-title":"Targeting PI3K-AKT\/mTOR signaling in the prevention of autism","volume":"147","author":"Sharma","year":"2021","journal-title":"Neurochem. Int."},{"issue":"March","key":"10.1016\/j.intimp.2026.116668_bb0055","article-title":"Therapeutic potential of baicalin against experimental obsessive compulsive disorder: evidence from CSF, blood plasma, and brain analysis","volume":"403","author":"Dhiman","year":"2025","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0060","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s12640-022-00480-z","article-title":"Activation of SIRT-1 signalling in the prevention of bipolar disorder and related neurocomplications: target activators and influences on neurological dysfunctions","volume":"40","author":"Rajkhowa","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.intimp.2026.116668_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuroscience.2025.01.021","article-title":"Disruptions in cellular communication: molecular interplay between glutamate\/NMDA signalling and MAPK pathways in neurological disorders","volume":"569","author":"Gupta","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2026.116668_bb0070","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04160","article-title":"Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide","volume":"13","author":"Huang","year":"2023","journal-title":"J. Glob. Health"},{"issue":"5","key":"10.1016\/j.intimp.2026.116668_bb0075","article-title":"The expanding burden of neurodegenerative diseases: an unmet medical and social need","volume":"16","author":"Wang","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.intimp.2026.116668_bb0080","series-title":"Brain sciences sex\u00a0: a significant risk factor for neurodevelopmental and neurodegenerative disorders","first-page":"1","author":"Pinares-garcia","year":"2018"},{"issue":"6","key":"10.1016\/j.intimp.2026.116668_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/gbb.12660","article-title":"Using the tools of genetic epidemiology to understand sex differences in neuropsychiatric disorders","volume":"19","author":"Merikangas","year":"2020","journal-title":"Genes Brain Behav."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-62820-7","article-title":"In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology","volume":"14","author":"Mosconi","year":"2024","journal-title":"Sci. Rep."},{"issue":"April","key":"10.1016\/j.intimp.2026.116668_bb0095","article-title":"Unveiling the potential of estrogen: exploring its role in neuropsychiatric disorders and exercise intervention","volume":"204","author":"He","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"March","key":"10.1016\/j.intimp.2026.116668_bb0100","article-title":"Functions of estrogen and estrogen receptor signaling on skeletal muscle","volume":"191","author":"Ikeda","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116668_bb0105","article-title":"Influence of the onset of menopause on the risk of developing Alzheimer\u2019s disease","volume":"16","author":"Briceno Silva","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.intimp.2026.116668_bb0110","series-title":"Estrogen Effects On Cognitive And Synaptic Health Over The Lifecourse","author":"Hara","year":"2015"},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0115","first-page":"1","article-title":"Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-na\u00efve postmenopausal Parkinson\u2019s disease","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.intimp.2026.116668_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12134274","article-title":"Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges","volume":"12","author":"Khan","year":"2023","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.intimp.2026.116668_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123107","article-title":"Sex hormones as key modulators of the immune response in multiple sclerosis: a review","volume":"10","author":"Murgia","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imm.13004","article-title":"Impact of sex hormones on immune function and multiple sclerosis development","volume":"156","author":"Ysrraelit","year":"2019","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/13697137.2021.1936485","article-title":"Selective estrogen receptor modulators and bone health","volume":"25","author":"Goldstein","year":"2022","journal-title":"Climacteric"},{"issue":"22","key":"10.1016\/j.intimp.2026.116668_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212121","article-title":"Raloxifene protects oxygen-glucose-deprived astrocyte cells used to mimic hypoxic-ischemic brain injury","volume":"25","author":"Toro-Urrego","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0145","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1007\/s12035-024-04497-7","article-title":"Raloxifene prevents chemically-induced ferroptotic neuronal death In Vitro and In Vivo","volume":"62","author":"Hao","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"20","key":"10.1016\/j.intimp.2026.116668_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21207586","article-title":"Raloxifene as treatment for various types of brain injuries and neurodegenerative diseases: a good start","volume":"21","author":"Veenman","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116668_bb0155","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9516592","article-title":"Translational significance of selective estrogen receptor modulators in psychiatric disorders","volume":"2018","author":"Khan","year":"2018","journal-title":"Int. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.intimp.2026.116668_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms17081357","article-title":"Tamoxifen resistance: emerging molecular targets","volume":"17","author":"Rond\u00f3n-Lagos","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116668_bb0165","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jsbmb.2014.05.003","article-title":"GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17\u03b2-estradiol in triple-negative breast cancer cells","volume":"143","author":"Yu","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1749-6632.2011.06086.x","article-title":"Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models","volume":"1229","author":"Furth","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2026.116668_bb0175","first-page":"892","article-title":"Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30\/GPER) from the plasma membrane towards the nucleus","volume":"76","author":"Cheng","year":"2011","journal-title":"Steroids"},{"issue":"10","key":"10.1016\/j.intimp.2026.116668_bb0180","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/17512433.2016.1231575","article-title":"Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women","volume":"9","author":"Provinciali","year":"2016","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116668_bb0185","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.neurobiolaging.2014.03.017","article-title":"Raloxifene activates G protein-coupled estrogen receptor 1\/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice","volume":"35","author":"Bourque","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/j.intimp.2026.116668_bb0190","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1517\/14656566.2013.782002","article-title":"The use of raloxifene in osteoporosis treatment","volume":"14","author":"P","year":"2013","journal-title":"Expert. Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0195","doi-asserted-by":"crossref","first-page":"138","DOI":"10.14348\/molcells.2015.2193","article-title":"Raloxifene induces autophagy-dependent cell death in breast cancer cells via the activation of amp-activated protein kinase","volume":"38","author":"Kim","year":"2015","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0200","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3892\/ijo.2015.3252","article-title":"A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines","volume":"48","author":"Taurin","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116668_bb0205","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/10717544.2014.900153","article-title":"Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis","volume":"22","author":"Saini","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.intimp.2026.116668_bb0210","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.2147\/IJN.S173216","article-title":"Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment","volume":"13","author":"Nagai","year":"2018","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.intimp.2026.116668_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082073","article-title":"Formulation and evaluation of a self-microemulsifying drug delivery system of raloxifene with improved solubility and oral bioavailability","volume":"15","author":"Ansari","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.intimp.2026.116668_bb0220","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s13346-021-00990-x","article-title":"Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC","volume":"12","author":"Jain","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.intimp.2026.116668_bb0225","series-title":"Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer","first-page":"1","author":"Vora","year":"2022"},{"issue":"11","key":"10.1016\/j.intimp.2026.116668_bb0230","doi-asserted-by":"crossref","first-page":"9119","DOI":"10.1016\/j.aej.2022.02.051","article-title":"Solubility and solution thermodynamics of raloxifene hydrochloride in various (DMSO + water) compositions: solubility and solution thermodynamics of raloxifene hydrochloride","volume":"61","author":"Alyamani","year":"2022","journal-title":"Alex. Eng. J."},{"issue":"March","key":"10.1016\/j.intimp.2026.116668_bb0235","article-title":"Pharmacokinetic evaluation of the synergistic effect of raloxifene loaded transfersomes for transdermal delivery","volume":"63","author":"Mahmood","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.intimp.2026.116668_bb0240","first-page":"1437","article-title":"Selective estrogen receptor modulators: tissue specificity and clinical utility","volume":"9","author":"Martinkovich","year":"2014","journal-title":"Clin. Interv. Aging"},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0245","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/jcp.27481","article-title":"Raloxifene attenuates oxidative stress and preserves mitochondrial function in astrocytic cells upon glucose deprivation","volume":"234","author":"Vesga-Jim\u00e9nez","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2026.116668_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2014.00132","article-title":"Selective estrogen receptor modulators regulate reactive microglia after penetrating brain injury","volume":"6","author":"Barreto","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0255","first-page":"1","article-title":"Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-025-89915-z","article-title":"Risk-benefits assessment of tamoxifen or raloxifene as chemoprevention for risk reduction of breast cancer among BRCA1 and BRCA2 carriers: a meta-analysis","volume":"15","author":"Alwashmi","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2478\/afpuc-2023-0003","article-title":"Role of raloxifene in the management of postmenopausal osteoporosis of rheumatoid arthritis patients","volume":"70","author":"Salari","year":"2023","journal-title":"Eur Pharm J."},{"issue":"July","key":"10.1016\/j.intimp.2026.116668_bb0270","article-title":"Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: systemic review and meta-analysis","volume":"13","author":"Wu","year":"2020","journal-title":"Bone Rep."},{"issue":"6","key":"10.1016\/j.intimp.2026.116668_bb0275","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/schbul\/sbad058","article-title":"The direct and long-term effects of raloxifene as adjunctive treatment for schizophrenia-spectrum disorders: a double-blind, randomized clinical trial","volume":"49","author":"Brand","year":"2023","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.intimp.2026.116668_bb0280","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1280237","article-title":"Drug repurposing for Alzheimer\u2019s disease based on protein-protein interaction network","volume":"2021","author":"Soleimani Zakeri","year":"2021","journal-title":"Biomed. Res. Int."},{"issue":"9","key":"10.1016\/j.intimp.2026.116668_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091405","article-title":"Peering into the brain\u2019s estrogen receptors: PET tracers for visualization of nuclear and extranuclear estrogen receptors in brain disorders","volume":"13","author":"Arjmand","year":"2023","journal-title":"Biomolecules"},{"issue":"May","key":"10.1016\/j.intimp.2026.116668_bb0290","article-title":"Exploring the physiological role of the G protein-coupled estrogen receptor (GPER) and its associations with human diseases","volume":"166","author":"\u017babi\u0144ska","year":"2024","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0295","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/rmb2.12006","article-title":"Molecular mechanism of estrogen\u2013estrogen receptor signaling","volume":"16","author":"Ya\u015far","year":"2017","journal-title":"Reprod. Med. Biol."},{"issue":"April","key":"10.1016\/j.intimp.2026.116668_bb0300","first-page":"1","article-title":"Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action","volume":"19","author":"Kim","year":"2025","journal-title":"Oncol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0305","first-page":"1","article-title":"Targeting GPER1 to suppress autophagy as a male-specific therapeutic strategy for iron-induced striatal injury","volume":"9","author":"Chen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116668_bb0310","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.physbeh.2015.05.017","article-title":"Rapid effects of the G-protein coupled oestrogen receptor (GPER) on learning and dorsal hippocampus dendritic spines in female mice","volume":"149","author":"Gabor","year":"2015","journal-title":"Physiol. Behav."},{"issue":"January","key":"10.1016\/j.intimp.2026.116668_bb0315","article-title":"The neuroprotective effects of estrogen and estrogenic compounds in spinal cord injury","volume":"146","author":"Shvetcov","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.intimp.2026.116668_bb0320","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2016.08.004","article-title":"Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson\u2019s disease","volume":"48","author":"Poirier","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.intimp.2026.116668_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbt.22395","article-title":"Raloxifene alleviates amyloid-\u03b2-induced cytotoxicity in HT22 neuronal cells via inhibiting oligomeric and fibrillar species formation","volume":"33","author":"Liu","year":"2019","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116668_bb0330","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mp.2015.11","article-title":"Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia","volume":"20","author":"Weickert","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.intimp.2026.116668_bb0335","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4759963","article-title":"Mechanisms of mitochondrial malfunction in Alzheimer\u2019s disease: new therapeutic hope","volume":"2022","author":"Nabi","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0340","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0345","first-page":"1","article-title":"Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer\u2019s disease and cognitive functions","volume":"10","author":"Liu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116668_bb0350","series-title":"Neuroprotective Potential of Raloxifene via G-Protein-Coupled","first-page":"1","author":"Receptors","year":"2023"},{"issue":"5","key":"10.1016\/j.intimp.2026.116668_bb0355","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: An endocrine society clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2026.116668_bb0360","doi-asserted-by":"crossref","unstructured":"Journal T, Endocrinology C, Copyright M, Endocrine T, Vol S. Printed in U.S.A. 1422. 2015;86(3):1422\u20134.","DOI":"10.1002\/srin.201570122"},{"issue":"August","key":"10.1016\/j.intimp.2026.116668_bb0365","article-title":"Amelioration of visual deficits and visual system pathology after mild TBI via the cannabinoid Type-2 receptor inverse agonism of raloxifene","volume":"322","author":"Honig","year":"2019","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0370","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0375","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1001-7844(13)60001-2","article-title":"Neuroprotective Effects of Raloxifene on A\u03b225\u201335-induced Damages in PC12 Cells via Mitogen-activated Protein Kinase Signaling Pathway","volume":"23","author":"Dai","year":"2012","journal-title":"J. Reprod. Contracept."},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0385","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1677\/joe.1.05775","article-title":"Both estrogen and raloxifene protect against \u03b2-amyloid-induced neurotoxicity in estrogen receptor \u03b1-transfected PC12 cells by activation of telomerase activity via Akt cascade","volume":"183","author":"Du","year":"2004","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0390","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JPD-150543","article-title":"Role of different alpha-synuclein strains in synucleinopathies, similarities with other neurodegenerative diseases","volume":"5","author":"Melki","year":"2015","journal-title":"J. Parkinsons Dis."},{"issue":"8","key":"10.1016\/j.intimp.2026.116668_bb0395","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3233\/JPD-230230","article-title":"Association between Menopausal Hormone Therapy and Risk for Parkinson\u2019s Disease","volume":"13","author":"Yuk","year":"2023","journal-title":"J. Parkinsons Dis."},{"issue":"10","key":"10.1016\/j.intimp.2026.116668_bb0400","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.intimp.2026.116668_bb0405","doi-asserted-by":"crossref","unstructured":"Rocha EM, De Miranda B, Sanders LH. Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Neurobiol. Dis. 2018;109:249\u201357.","DOI":"10.1016\/j.nbd.2017.04.004"},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0410","first-page":"1","article-title":"\u57fa\u56e0\u7684\u6539\u53d8NIH Public Access","volume":"23","author":"Nguyen","year":"2011","journal-title":"Science (80-)."},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0415","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neurobiolaging.2012.05.022","article-title":"Implication of GPER1 in neuroprotection in a mouse model of Parkinson\u2019s disease","volume":"34","author":"Bourque","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"19\u201320","key":"10.1016\/j.intimp.2026.116668_bb0420","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.lfs.2011.03.010","article-title":"The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson\u2019s disease","volume":"88","author":"Baraka","year":"2011","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0425","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/syn.1067","article-title":"Neuroprotective properties of 17\u03b2-estradiol, progesterone, and raloxifene in MPTP C57Bl\/6 mice","volume":"41","author":"Callier","year":"2001","journal-title":"Synapse"},{"issue":"January","key":"10.1016\/j.intimp.2026.116668_bb0430","article-title":"Review of multiple sclerosis","volume":"8","author":"Review","year":"2024"},{"issue":"8","key":"10.1016\/j.intimp.2026.116668_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/genes13081324","article-title":"Nrf2\/HO-1 signaling stimulation through acetyl-11-keto-beta-boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis","volume":"13","author":"Upadhayay","year":"2022","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.intimp.2026.116668_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2021.100139","article-title":"Inhibition of c-JNK\/p38MAPK signaling pathway by apigenin prevents neurobehavioral and neurochemical defects in ethidium bromide-induced experimental model of multiple sclerosis in rats: evidence from CSF, blood plasma and brain samples","volume":"1","author":"Singh","year":"2021","journal-title":"Phytomed. Plus"},{"key":"10.1016\/j.intimp.2026.116668_bb0445","first-page":"2702","article-title":"Review astrocytes in multiple sclerosis\u00a0: a product of their environment","volume":"65","author":"Nair","year":"2008"},{"key":"10.1016\/j.intimp.2026.116668_bb0450","series-title":"the Priming Phase of the Immune Response 1","author":"Liston","year":"2015"},{"issue":"4","key":"10.1016\/j.intimp.2026.116668_bb0455","article-title":"Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-\u03baB-dependent CCL20 expression in reactive astrocytes","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2026.116668_bb0460","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3892\/ijmm.2013.1306","article-title":"Lentivirus-mediated estrogen receptor a overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice","volume":"31","author":"Hu","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116668_bb0465","first-page":"195","article-title":"Genetic alterations in the mouse myelin basic proteins result in a range of dysmyelinating disorders","volume":"228","author":"Jacobs","year":"2005"},{"key":"10.1016\/j.intimp.2026.116668_bb0470","series-title":"Multiple sclerosis","volume":"9","author":"Fainardi","year":"2006"},{"key":"10.1016\/j.intimp.2026.116668_bb0475","series-title":"3 utr C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis","first-page":"36","volume":"431","author":"Illes","year":"2008"},{"issue":"11","key":"10.1016\/j.intimp.2026.116668_bb0480","first-page":"1123","article-title":"Interleukin 17 \u2013 producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005"},{"key":"10.1016\/j.intimp.2026.116668_bb0485","series-title":"Production and functions of IL-17 in microglia","first-page":"54","volume":"194","author":"Kawanokuchi","year":"2008"},{"issue":"7","key":"10.1016\/j.intimp.2026.116668_bb0490","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/glia.20805","article-title":"Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis","volume":"57","author":"Bebo","year":"2009","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0495","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/joe.1.06063","article-title":"Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands","volume":"185","author":"Elloso","year":"2005","journal-title":"J. Endocrinol."},{"issue":"01","key":"10.1016\/j.intimp.2026.116668_bb0500","doi-asserted-by":"crossref","first-page":"41","DOI":"10.56933\/Pharmaspire.2023.15108","article-title":"Overview of amyotrophic lateral sclerosis and medications for disease progression","volume":"15","author":"Sharma","year":"2023","journal-title":"Pharmaspire"},{"issue":"5","key":"10.1016\/j.intimp.2026.116668_bb0505","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/1871527320666210126113848","article-title":"Understanding abnormal c-JNK\/p38MAPK signaling in amyotrophic lateral sclerosis: potential drug targets and influences on neurological disorders","volume":"20","author":"Yadav","year":"2021","journal-title":"CNS & Neurological Disorders"},{"key":"10.1016\/j.intimp.2026.116668_bb0510","series-title":"Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis","author":"Philips","year":"2013"},{"issue":"5","key":"10.1016\/j.intimp.2026.116668_bb0515","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn.3357","article-title":"Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis","volume":"16","author":"Kang","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2026.116668_bb0520","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.brainresbull.2018.05.017","article-title":"Raloxifene, a promising estrogen replacement, limits TDP-25 cell death by enhancing autophagy and suppressing apoptosis","volume":"140","author":"Zhou","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2026.116668_bb0525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2013.05.023","article-title":"Molecular and cellular endocrinology the nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs)","volume":"376","author":"Pupo","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116668_bb0530","doi-asserted-by":"crossref","DOI":"10.1172\/JCI42986","article-title":"Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis","volume":"120","author":"Reyes","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0535","first-page":"1","article-title":"Raloxifene is a female-specific proteostasis therapeutic in the spinal cord","volume":"162","author":"Jenkins","year":"2021","journal-title":"Endocrinol (United States)."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0540","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","article-title":"Schizophrenia - an overview","volume":"77","author":"McCutcheon","year":"2020","journal-title":"JAMA Psychiatr."},{"issue":"7321","key":"10.1016\/j.intimp.2026.116668_bb0545","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"issue":"1\u20133","key":"10.1016\/j.intimp.2026.116668_bb0550","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.schres.2010.05.014","article-title":"Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8","volume":"121","author":"Ellman","year":"2010","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0555","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.intimp.2026.116668_bb0560","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1176\/appi.ajp.159.7.1080","article-title":"Obstetric complications and schizophrenia: historical and meta-analytic review. American Journal of Psychiatry, 159(7), pp.1080\u20131092. schizophrenia: historical and meta-analytic revi","volume":"159","author":"Cannon","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.intimp.2026.116668_bb0565","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.294.5.557","article-title":"Rates of adult schizophrenia following of 1959\u20131961","volume":"294","author":"St. Clair","year":"2005","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.intimp.2026.116668_bb0570","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2013.155","article-title":"Schizophrenia is a cognitive illness: time for a change in focus","volume":"70","author":"Kahn","year":"2013","journal-title":"JAMA Psychiatry."},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2026.116668_bb0575","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0306-4530(02)00125-7","article-title":"Gender differences in schizophrenia","volume":"28","author":"H\u00e4fner","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2026.116668_bb0580","article-title":"Neuroprotective actions of selective estrogen receptor modulators","volume":"34","author":"DonCarlos","year":"2009","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0585","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuroscience.2007.04.037","article-title":"Raloxifene acutely reduces glutamate-induced intracellular calcium increase in cultured rat cortical neurons via inhibition of high-voltage-activated calcium current","volume":"147","author":"Huang","year":"2007","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.intimp.2026.116668_bb0590","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamapsychiatry.2016.1383","article-title":"Effect of adjunctive raloxifene therapy on severity of refractory schizophrenia in women: a randomized clinical trial","volume":"73","author":"Kulkarni","year":"2016","journal-title":"JAMA Psychiatry."},{"issue":"8","key":"10.1016\/j.intimp.2026.116668_bb0595","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.psyneuen.2010.01.014","article-title":"Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia","volume":"35","author":"Kulkarni","year":"2010","journal-title":"Psychoneuroendocrinology"},{"issue":"October 2018","key":"10.1016\/j.intimp.2026.116668_bb0600","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.psyneuen.2018.10.001","article-title":"Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status","volume":"100","author":"Gurvich","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0605","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.euroneuro.2013.11.012","article-title":"Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial","volume":"24","author":"Huerta-Ramos","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116668_bb0610","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00406-019-01079-w","article-title":"Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial","volume":"270","author":"Huerta-Ramos","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.intimp.2026.116668_bb0615","series-title":"Subjects S. C O G N I T I V E F U N C T I O N I N P O St M E N O Pausa L Wo M E N T R E At E D W I T H R a L Ox I F E N E Cognitive Function in Postmenopausal Women Treated","first-page":"1207","year":"2001"},{"issue":"4","key":"10.1016\/j.intimp.2026.116668_bb0620","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.162.4.683","article-title":"Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial","volume":"162","author":"Yaffe","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"31","key":"10.1016\/j.intimp.2026.116668_bb0625","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1200\/JCO.2008.21.0716","article-title":"Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene","volume":"27","author":"Legault","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0630","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.maturitas.2003.07.003","article-title":"Effects of raloxifene on mood, sleep, libido and cognitive function in postmenopausal healthy women: a pilot study","volume":"48","author":"Natale","year":"2004","journal-title":"Maturitas"},{"issue":"16","key":"10.1016\/j.intimp.2026.116668_bb0635","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neubiorev.2015.08.013","article-title":"Putting age-related task activation into large-scale brain networks: a meta-analysis of 114 fMRI studies on healthy aging","volume":"57","author":"Li","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"12","key":"10.1016\/j.intimp.2026.116668_bb0640","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.euroneuro.2016.10.009","article-title":"Raloxifene increases prefrontal activity during emotional inhibition in schizophrenia based on estrogen receptor genotype","volume":"26","author":"Kindler","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116668_bb0645","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1503\/jpn.110088","article-title":"Reduced neural activity of the prefrontal cognitive control circuitry during response inhibition to negative words in people with schizophrenia","volume":"37","author":"Vercammen","year":"2012","journal-title":"J. Psychiatry Neurosci."},{"issue":"December 2015","key":"10.1016\/j.intimp.2026.116668_bb0650","article-title":"Adjunctive selective estrogen receptor modulator increases neural activity in the hippocampus and inferior frontal gyrus during emotional face recognition in schizophrenia","volume":"6","author":"Ji","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0655","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuroimage.2004.11.012","article-title":"Raloxifene exposure enhances brain activation during memory performance in healthy elderly males; its possible relevance to behavior","volume":"25","author":"Goekoop","year":"2005","journal-title":"Neuroimage"},{"issue":"7","key":"10.1016\/j.intimp.2026.116668_bb0660","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/sj.npp.1300956","article-title":"Raloxifene treatment enhances brain activation during recognition of familiar items: a pharmacological fMRI study in healthy elderly males","volume":"31","author":"Goekoop","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.intimp.2026.116668_bb0665","article-title":"Anxiety and depression in midlife transition and beyond: the role of estrogens","volume":"31","author":"Soares","year":"2023","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.116668_bb0670","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1139\/jpn.0831","article-title":"Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?","volume":"33","author":"Soares","year":"2008","journal-title":"J. Psychiatry Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0675","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.fertnstert.2007.02.035","article-title":"The effects of raloxifen on depression and cognition in ovariectomized rats","volume":"89","author":"Karahancer","year":"2008","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0680","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbr.2011.10.036","article-title":"Antidepressive and anxiolytic activity of selective estrogen receptor modulators in ovariectomized mice submitted to chronic unpredictable stress","volume":"227","author":"Calmarza-Font","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0685","first-page":"1","article-title":"\u57fa\u56e0\u7684\u6539\u53d8NIH Public Access","volume":"23","author":"Wu","year":"2011","journal-title":"Natl Inst Heal."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0690","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/gme.0b013e3181bd54df","article-title":"Raloxifene improves verbal memory in late postmenopausal women: a randomized, double-blind, placebo-controlled trial","volume":"17","author":"Jacobsen","year":"2010","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.intimp.2026.116668_bb0695","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/cxo.12670","article-title":"Visual problems associated with traumatic brain injury","volume":"101","author":"Armstrong","year":"2018","journal-title":"Clin. Exp. Optom."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0700","first-page":"52","article-title":"Neurologic care in concussion and post-concussive encephalopathy","volume":"46","author":"Chadehumbe","year":"2016","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"issue":"May","key":"10.1016\/j.intimp.2026.116668_bb0705","first-page":"1","article-title":"Characterizing the risk of depression following mild traumatic brain injury: a meta-analysis of the literature comparing chronic mTBI to non-mTBI populations","volume":"11","author":"Hellewell","year":"2020","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0710","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/OPX.0000000000000825","article-title":"Visual dysfunctions at different stages after blast and non-blast mild traumatic brain injury","volume":"94","author":"Cap\u00f3-Aponte","year":"2017","journal-title":"Optom. Vis. Sci."},{"issue":"October","key":"10.1016\/j.intimp.2026.116668_bb0715","first-page":"1","article-title":"Raloxifene modulates microglia and rescues visual deficits and pathology after impact traumatic brain injury","volume":"15","author":"Honig","year":"2021","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0720","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbr.2006.02.026","article-title":"Administration of raloxifene reduces sensorimotor and working memory deficits following traumatic brain injury","volume":"170","author":"Kokiko","year":"2006","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0725","first-page":"534","article-title":"Raloxifene mitigates emotional deficits after mild traumatic brain injury in mice","volume":"3","author":"Honig","year":"2022","journal-title":"Neurotrauma Rep."},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0730","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/FBP.0b013e32833a5cb0","article-title":"Raloxifene and\/or estradiol decrease anxiety-like and depressive-like behavior, whereas only estradiol increases carcinogen-induced tumorigenesis and uterine proliferation among ovariectomized rats","volume":"21","author":"Walf","year":"2010","journal-title":"Behav. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0735","first-page":"1031","article-title":"Neuroscience and oxidative stress","volume":"13","author":"Raju Asirvatham","year":"2021","journal-title":"J. Cell. Neurosci. Oxid. Stress"},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0740","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0306-4522(03)00245-8","article-title":"Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice","volume":"121","author":"Lei","year":"2003","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0745","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neures.2011.06.004","article-title":"Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury","volume":"71","author":"Barreto","year":"2011","journal-title":"Neurosci. Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0750","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0197-4580(99)00108-6","article-title":"Aberrant expression of nitric oxide synthase III in Alzheimer\u2019s disease: relevance to cerebral vasculopathy and neurodegeneration","volume":"21","author":"De La Monte","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0755","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3940(02)01416-7","article-title":"The effects of estrogen and raloxifene treatment on the antioxidant enzymes and nitrite-nitrate levels in brain cortex of ovariectomized rats","volume":"338","author":"\u00d6ge","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0760","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/cbf.1328","article-title":"The potential antioxidant effect of raloxifene treatment: A study on heart, liver and brain cortex of ovariectomized female rats","volume":"25","author":"Konyalioglu","year":"2007","journal-title":"Cell Biochem. Funct."},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0765","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s12035-016-9727-3","article-title":"Modulation of Diabetes-Induced Oxidative Stress, Apoptosis, and Ca2+ Entry Through TRPM2 and TRPV1 Channels in Dorsal Root Ganglion and Hippocampus of Diabetic Rats by Melatonin and Selenium","volume":"54","author":"Kahya","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116668_bb0770","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1007\/s12035-015-9292-1","article-title":"Hypericum perforatum Attenuates Spinal Cord Injury-Induced Oxidative Stress and Apoptosis in the Dorsal Root Ganglion of Rats: Involvement of TRPM2 and TRPV1 Channels","volume":"53","author":"\u00d6zdemir","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116668_bb0775","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1007\/s12035-016-0232-5","article-title":"Ovariectomy-Induced Mitochondrial Oxidative Stress, Apoptosis, and Calcium Ion Influx Through TRPA1, TRPM2, and TRPV1 Are Prevented by 17\u03b2-Estradiol, Tamoxifen, and Raloxifene in the Hippocampus and Dorsal Root Ganglion of Rats","volume":"54","author":"Yaz\u011fan","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116668_bb0780","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1101\/lm.037267.114","article-title":"Sex steroid hormones matter for learning and memory: Estrogenic regulation of hippocampal function in male and female rodents","volume":"22","author":"Frick","year":"2015","journal-title":"Learn. Mem."},{"issue":"10","key":"10.1016\/j.intimp.2026.116668_bb0785","first-page":"3706","article-title":"The selective estrogen receptor modulator raloxifene regulates arginine-vasopressin gene expression in human female neuroblastoma cells through G protein-coupled estrogen receptor and ERK signaling","volume":"156","author":"Grassi","year":"2015","journal-title":"Endocrinol (United States)."},{"issue":"October","key":"10.1016\/j.intimp.2026.116668_bb0790","first-page":"1","article-title":"Effects of estrogen and raloxifene on synaptic density in the hippocampal CA1 region of ovariectomized rats","volume":"78","author":"MenezesdaSilva","year":"2023","journal-title":"Clinics"},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0795","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.expneurol.2003.09.005","article-title":"Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer\u2019s disease","volume":"185","author":"O\u2019Neill","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2026.116668_bb0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/309494","article-title":"Selective estrogen receptor modulators regulate dendritic spine plasticity in the hippocampus of male rats","volume":"2012","author":"Gonz\u00e1lez-Burgos","year":"2012","journal-title":"Neural Plast"},{"key":"10.1016\/j.intimp.2026.116668_bb0805","series-title":"Vols. 1\u20133, Encyclopedia of Behavioral Neuroscience: Volumes 1\u20133, Second edition","article-title":"Short-Term and Working Memory","author":"Allen","year":"2021"},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2007.05.002","article-title":"Spatial organization of direct hippocampal field CA1 axonal projections to the rest of the cerebral cortex","volume":"56","author":"Cenquizca","year":"2007","journal-title":"Brain Res. Rev."},{"issue":"7","key":"10.1016\/j.intimp.2026.116668_bb0815","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/cercor\/13.7.782","article-title":"Synaptic influence of hippocampus on pyramidal cells of the rat prefrontal cortex: an in vivo intracellular recording study","volume":"13","author":"D\u00e9gen\u00e8tais","year":"2003","journal-title":"Cereb. Cortex"},{"issue":"4","key":"10.1016\/j.intimp.2026.116668_bb0820","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.yhbeh.2012.01.010","article-title":"Effects of selective estrogen receptor modulators on allocentric working memory performance and on dendritic spines in medial prefrontal cortex pyramidal neurons of ovariectomized rats","volume":"61","author":"Vel\u00e1zquez-Zamora","year":"2012","journal-title":"Horm. Behav."},{"issue":"4","key":"10.1016\/j.intimp.2026.116668_bb0825","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0306-4530(01)00054-3","article-title":"Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques","volume":"27","author":"Bethea","year":"2002","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.intimp.2026.116668_bb0830","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0306-4530(03)00118-5","article-title":"Effects of raloxifene and estradiol on hippocampal acetylcholine release and spatial learning in the rat","volume":"29","author":"Gibbs","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0835","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0893-133X(01)00233-0","article-title":"Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain","volume":"25","author":"Cyr","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0840","doi-asserted-by":"crossref","DOI":"10.1038\/s41537-017-0043-3","article-title":"The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis","volume":"4","author":"De Boer","year":"2018","journal-title":"NPJ Schizophr."},{"issue":"4","key":"10.1016\/j.intimp.2026.116668_bb0845","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.maturitas.2013.05.010","article-title":"Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: a systematic review of randomized controlled trials","volume":"75","author":"Yang","year":"2013","journal-title":"Maturitas"},{"issue":"22","key":"10.1016\/j.intimp.2026.116668_bb0850","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.0000000000002171","article-title":"Raloxifene for women with Alzheimer disease","volume":"85","author":"Henderson","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0855","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/WNN.0000000000000131","article-title":"Semantic memory in the clinical progression of Alzheimer disease","volume":"30","author":"Tchakoute","year":"2017","journal-title":"Cogn. Behav. Neurol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116668_bb0860","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/schbul\/sbv149","article-title":"Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: A 24-week double-blind, randomized, parallel, placebo-controlled trial","volume":"42","author":"Usall","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.intimp.2026.116668_bb0865","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/npp.2015.88","article-title":"Selective estrogen receptor modulation increases hippocampal activity during probabilistic association learning in schizophrenia","volume":"40","author":"Kindler","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.intimp.2026.116668_bb0870","unstructured":"Impairment H, Hyperparathyroidism P. This label may not be the latest approved by FDA. For current labeling information, please visit https:\/\/www.fda.gov\/drugsatfda Reference ID\u00a0: 2981969 This label may not be the latest approved by FDA. For current labeling information, please visit htt. 2011;1\u201318."},{"key":"10.1016\/j.intimp.2026.116668_bb0875","series-title":"Practice Guidline For The Treatment of Patients With Schizophrenia, Third Edition","first-page":"297","author":"American Psychiatric Association","year":"2021"},{"key":"10.1016\/j.intimp.2026.116668_bb0880","series-title":"Psychosis and schizophrenia in adults: prevention and management","first-page":"4","author":"National Institute for Health and Care Excellence (NICE)","year":"2014"},{"issue":"3","key":"10.1016\/j.intimp.2026.116668_bb0885","doi-asserted-by":"crossref","first-page":"183","DOI":"10.6118\/jmm.2018.24.3.183","article-title":"The beneficial and adverse effects of raloxifene in menopausal women: a mini review","volume":"24","author":"Khorsand","year":"2018","journal-title":"J. Menopausal Med."},{"key":"10.1016\/j.intimp.2026.116668_bb0895","author":"HSJ"},{"key":"10.1016\/j.intimp.2026.116668_bb0905","author":"(NIA) NI on A, editor"},{"key":"10.1016\/j.intimp.2026.116668_bb0910","author":"(NIA) NI on A, editor"},{"key":"10.1016\/j.intimp.2026.116668_bb0920","series-title":"Sex differences in Alzheimer disease \u2014 the gateway to precision medicine","author":"Ferretti","year":"2018"},{"issue":"6","key":"10.1016\/j.intimp.2026.116668_bb0925","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00774-012-0365-1","article-title":"Safety and effectiveness profile of raloxifene in long-term, prospective, postmarketing surveillance","volume":"30","author":"Iikuni","year":"2012","journal-title":"J. Bone Miner. Metab."},{"issue":"22","key":"10.1016\/j.intimp.2026.116668_bb0930","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1001\/archinte.160.22.3444","article-title":"Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials","volume":"160","author":"Johnston","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116668_bb0935","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S8756-3282(03)00241-2","article-title":"Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial","volume":"33","author":"Delmas","year":"2003","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.intimp.2026.116668_bb0940","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jmig.2006.06.015","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes","volume":"13","author":"Corson","year":"2006","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0945","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJWH.S3894","article-title":"Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update","volume":"1","author":"Messalli","year":"2009","journal-title":"Int. J. Women\u2019s Health"},{"issue":"4","key":"10.1016\/j.intimp.2026.116668_bb0950","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.AOG.0000137349.79204.b8","article-title":"Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation","volume":"104","author":"Grady","year":"2004","journal-title":"Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116668_bb0955","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1185\/030079905X61839","article-title":"Safety assessment of raloxifene over eight years in a clinical trial setting","volume":"21","author":"Martino","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb0960","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00737-017-0773-2","article-title":"Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a meta-analysis of randomized controlled trials","volume":"21","author":"Wang","year":"2018","journal-title":"Arch. Womens. Ment. Health"},{"issue":"8","key":"10.1016\/j.intimp.2026.116668_bb0965","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.amjmed.2009.01.033","article-title":"Raloxifene and risk for stroke based on the Framingham Stroke Risk Score","volume":"122","author":"Barrett-Connor","year":"2009","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.116668_bb0970","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/gme.0b013e3181a15622","article-title":"Raloxifene and stroke risks in Japanese postmenopausal women with osteoporosis on postmarketing surveillance","volume":"16","author":"Urushihara","year":"2009","journal-title":"Menopause"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2026.116668_bb0975","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2009.05.044","article-title":"Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: A study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10","volume":"378","author":"Mizuma","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.intimp.2026.116668_bb0980","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.3390\/molecules15118478","article-title":"The pharmacokinetics of raloxifene and its interaction with apigenin in rat","volume":"15","author":"Chen","year":"2010","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.intimp.2026.116668_bb0985","doi-asserted-by":"crossref","DOI":"10.3390\/life13071612","article-title":"Hemostatic effects of raloxifene in ovariectomized rats","volume":"13","author":"Alva-Chavarr\u00eda","year":"2023","journal-title":"Life"},{"issue":"March","key":"10.1016\/j.intimp.2026.116668_bb0990","article-title":"Interaction between apigenin and sodium deoxycholate with raloxifene: a potential risk for clinical practice","volume":"161","author":"Aleksandar","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"June","key":"10.1016\/j.intimp.2026.116668_bb0995","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejps.2014.05.018","article-title":"Raloxifene preserves phenytoin and sodium valproate induced bone loss by modulating serum estradiol and TGF-\u03b23 content in bone of female mice","volume":"62","author":"Anwar","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2026.116668_bb1000","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1023\/A:1010904815275","article-title":"Divergent effects of raloxifene HCl on the the pharmacokinetics and pharmacodynamics of warfarin","volume":"18","author":"Miller","year":"2001","journal-title":"Pharm. Res."},{"issue":"Oct","key":"10.1016\/j.intimp.2026.116668_bb1005","first-page":"8","article-title":"Raloxifene improves cognition in schizophrenia: spurious result or valid effect?","volume":"8","author":"Weickert","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.intimp.2026.116668_bb1010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mce.2017.08.014","article-title":"Bazedoxifene and raloxifene protect neocortical neurons undergoing hypoxia via targeting ER\u03b1 and PPAR-\u03b3","volume":"461","author":"Rzemieniec","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.intimp.2026.116668_bb1015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jsbmb.2014.05.005","article-title":"Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ER\u03b1 but not ER\u03b2 or GPR30 signalling","volume":"146","author":"Rzemieniec","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"May","key":"10.1016\/j.intimp.2026.116668_bb1020","first-page":"1","article-title":"Neuroprotection in acute ischemic stroke: a battle against the biology of nature","volume":"13","author":"Ghozy","year":"2022","journal-title":"Front. Neurol."},{"issue":"August 2024","key":"10.1016\/j.intimp.2026.116668_bb1025","article-title":"Genetic variants in COMT and ESR1 genes shape treatment response to raloxifene in schizophrenia-spectrum disorders","volume":"172","author":"Brand","year":"2025","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.intimp.2026.116668_bb1030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41418-021-00844-6","article-title":"Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection","volume":"29","author":"Allegretti","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2026.116668_bb1035","series-title":"Raloxifene hydrochloride","first-page":"1669","volume":"57","author":"Review C","year":"2000"},{"key":"10.1016\/j.intimp.2026.116668_bb1040","series-title":"Drug transport across the blood \u2013 brain barrier","first-page":"1959","volume":"June","author":"Pardridge","year":"2012"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926005138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926005138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:56:19Z","timestamp":1778820979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926005138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":205,"alternative-id":["S1567576926005138"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116668","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raloxifene Beyond Osteoporosis: Unlocking Neurorestoration Through Remyelination, Inflammatory Regulation, and Neuroimmune Modulation in CNS Pathologies","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116668"}}